Characterization of protein kinases forming acid-labile histone phosphates in Walker-256 carcinosarcoma cell nuclei.
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002279:Carcinoma 256, Walker / Q000201:enzymology*; D002417:Cattle; D002458:Cell Fractionation; D002467:Cell Nucleus / Q000201:enzymology*; D002848:Chromatography, DEAE-Cellulose; D002852:Chromatography, Ion Exchange; D000242:Cyclic AMP / Q000494:pharmacology; D006152:Cyclic GMP / Q000494:pharmacology; D004355:Drug Stability; D006657:Histones / Q000378:metabolism*; D006863:Hydrogen-Ion Concentration; D008274:Magnesium / Q000494:pharmacology; D008345:Manganese / Q000494:pharmacology; D009943:Organophosphorus Compounds / Q000378:metabolism; D010761:Phosphorus Radioisotopes; D047428:Protein Kinase Inhibitors; D011494:Protein Kinases / Q000302:isolation & purification / Q000378:metabolism*; D051381:Rats; D013329:Structure-Activity Relationship; D013950:Thymus Gland
D006657:Histones; D009943:Organophosphorus Compounds; D010761:Phosphorus Radioisotopes; D047428:Protein Kinase Inhibitors; D008345:Manganese; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D011494:Protein Kinases; D006152:Cyclic GMP; D008274:Magnesium; D002118:Calcium